WEKO3
アイテム
{"_buckets": {"deposit": "aa288766-2a0a-4e83-a9a8-77a82a9483bc"}, "_deposit": {"created_by": 3, "id": "644", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "644"}, "status": "published"}, "_oai": {"id": "oai:dmu.repo.nii.ac.jp:00000644", "sets": ["45"]}, "author_link": ["2645", "2644"], "item_2_biblio_info_12": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2008-03-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "36", "bibliographicPageStart": "27", "bibliographicVolumeNumber": "35", "bibliographic_titles": [{"bibliographic_title": "Dokkyo journal of medical sciences"}]}]}, "item_2_description_10": {"attribute_name": "抄録(日)", "attribute_value_mlt": [{"subitem_description": "近年,強力な骨吸収抑制作用を持つビスフォスフォネート製剤が骨粗鬆症の治療に使用されている.長期間(3年以上,平均±SE:6.0±1.2年)のホルモン補充療法(hormone replacement therapy:HRT)を施行中の骨量減少患者を対象にリセドロネート2.5mg/日を投与し[Risedronate (Ris)+HRT群, n=11],投与前と投与後42ヶ月間, 6ヶ月に1回,骨密度(bone mineral density:BMD)を測定した.また,長期HRT施行中でBMDが正常の比較的高齢女性(HRT単独群,平均59.7±1.6歳, n=13),およびHRTを行っていないがBMDが正常の高齢女性(無治療群,平均57.3±1.6歳, n=20)の42ヶ月にわたるBMDの変化を比較した. Ris+HRT群のBMDは投与開始後全期間を通じて持続的に有意に増加した. HRT単独群のBMDは全期間を通じて有意な変化を認めなかったが,無治療群のBMDは,観察開始後18~42ヶ月で有意に低下した.これらより長期HRT施行中の骨量減少患者に対するリセドロネートのBMD増加効果を明らかにした.また,高齢女性における長期HRT (半量投与を含む)のBMD維持効果が判明した.", "subitem_description_type": "Other"}]}, "item_2_description_11": {"attribute_name": "抄録(英)", "attribute_value_mlt": [{"subitem_description": "Hormone replacement therapy (HRT) improves the bone mineral density (BMD) of postmenopausal patients with osteoporosis or osteopenia. However, treatment with long-term HRT for more than 3 years diminishes an increasing effect on BMD but prevents further bone loss. The present studies were designed to investigate the effects of rise-dronate (Ris), a pyridinyl bisphosphonate, on BMD in osteopenic postmenopausal women with a mean age of 50.3±2.9 years who had received long-term HRT for more than 3 years and of long-term HRT on BMD in relatively older women with normal BMD. 2.5mg daily of risedronate was administered for 42 months to 11 osteopenic postmenopausal women treated with long-term HRT, the duration of which was 6.0±1.2 years (Ris+HRT group). BMD and biochemical bone markers were determined at the initiation of observation and thereafter every 6 months for 42 months in the above-mentioned 11 osteopenic women, 13 relatively older women with a mean age of 59.2±1.6 years who had received long-term HRT for an average of 6.1±0.7 years (HRT group) and other 20 relatively older women with a mean age of 57.3±1.6 years who had never received HRT (non-HRT group), The BMD in the women of both older groups were normal when the study was initiated. Percent changes of BMD in the Ris+HRT group were significantly increased all through the 42 months. Those in the HRT group did not show any significant changes for 42 months and those in the non-HRT group were significantly decreased between 18 and 42 months after the initiation of observation. These results indicate that Ris significantly increases the BMD in those who had received long-term HRT and treatment with long-term HRT including half a dose of HRT is effective for maintaining the BMD in older postmenopausal women.", "subitem_description_type": "Other"}]}, "item_2_description_15": {"attribute_name": "表示順", "attribute_value_mlt": [{"subitem_description": "7", "subitem_description_type": "Other"}]}, "item_2_description_16": {"attribute_name": "アクセション番号", "attribute_value_mlt": [{"subitem_description": "KJ00005058748", "subitem_description_type": "Other"}]}, "item_2_description_8": {"attribute_name": "記事種別(日)", "attribute_value_mlt": [{"subitem_description": "原著", "subitem_description_type": "Other"}]}, "item_2_description_9": {"attribute_name": "記事種別(英)", "attribute_value_mlt": [{"subitem_description": "Original", "subitem_description_type": "Other"}]}, "item_2_source_id_1": {"attribute_name": "雑誌書誌ID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00629581", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_19": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "03855023", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_6": {"attribute_name": "著者所属(日)", "attribute_value_mlt": [{"subitem_text_value": "獨協医科大学越谷病院産科婦人科"}]}, "item_2_text_7": {"attribute_name": "著者所属(英)", "attribute_value_mlt": [{"subitem_text_language": "en", "subitem_text_value": "Department of Obstetrics and Gynecology, Dokkyo Medical University Koshigaya Hospital"}]}, "item_2_title_3": {"attribute_name": "論文名よみ", "attribute_value_mlt": [{"subitem_title": "チョウキ ホルモン ホジュウ リョウホウ (hormone replacement therapy:HRT) シコウチュウ ノ コツリョウ ゲンショウ ヘイケイゴ ジョセイ ノ コツミツド ニ タイスル ビスフォスフォネート セイザイ ヘイヨウ コウカ ト チョウキ HRT シコウチュウ ノ コウレイ ジョセイ 二オケル コツミツド ノ ヘンカ ニ カンスル リンショウテキ ケンキュウ"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "濱田, 佳伸"}, {"creatorName": "ハマダ, ヨシノブ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "2644", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hamada, Yoshinobu", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "2645", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-05-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00005058748.pdf", "filesize": [{"value": "813.0 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 813000.0, "url": {"label": "KJ00005058748.pdf", "url": "https://dmu.repo.nii.ac.jp/record/644/files/KJ00005058748.pdf"}, "version_id": "2fbb5dee-eb67-4ebd-8723-e058f2971caa"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "骨量減少", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ホルモン補充療法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "リセドロネート", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ビスフォスフォネート", "subitem_subject_scheme": "Other"}, {"subitem_subject": "骨代謝マーカー", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "長期ホルモン補充療法(hormone replacement therapy:HRT)施行中の骨量減少閉経後女性の骨密度に対するビスフォスフォネート製剤併用効果と長期HRT施行中の高齢女性における骨密度の変化に関する臨床的研究", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "長期ホルモン補充療法(hormone replacement therapy:HRT)施行中の骨量減少閉経後女性の骨密度に対するビスフォスフォネート製剤併用効果と長期HRT施行中の高齢女性における骨密度の変化に関する臨床的研究"}, {"subitem_title": "The Additive Effect of Risedronate, a Bisphosphonate, on the Bone Mineral Density (BMD) in Osteopenic Postmenopausal Women Treated with Long-term Hormone Replacement Therapy (HRT) and the Long-term HRT Effect on the BMD in Older Postmenopausal Women", "subitem_title_language": "en"}]}, "item_type_id": "2", "owner": "3", "path": ["45"], "permalink_uri": "https://dmu.repo.nii.ac.jp/records/644", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-05-24"}, "publish_date": "2017-05-24", "publish_status": "0", "recid": "644", "relation": {}, "relation_version_is_last": true, "title": ["長期ホルモン補充療法(hormone replacement therapy:HRT)施行中の骨量減少閉経後女性の骨密度に対するビスフォスフォネート製剤併用効果と長期HRT施行中の高齢女性における骨密度の変化に関する臨床的研究"], "weko_shared_id": 3}
長期ホルモン補充療法(hormone replacement therapy:HRT)施行中の骨量減少閉経後女性の骨密度に対するビスフォスフォネート製剤併用効果と長期HRT施行中の高齢女性における骨密度の変化に関する臨床的研究
https://dmu.repo.nii.ac.jp/records/644
https://dmu.repo.nii.ac.jp/records/6443f99fa42-ea01-45fa-a389-5f99bd143dba
名前 / ファイル | ライセンス | アクション |
---|---|---|
KJ00005058748.pdf (813.0 kB)
|
|
Item type | [ELS]学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-05-24 | |||||
タイトル | ||||||
タイトル | 長期ホルモン補充療法(hormone replacement therapy:HRT)施行中の骨量減少閉経後女性の骨密度に対するビスフォスフォネート製剤併用効果と長期HRT施行中の高齢女性における骨密度の変化に関する臨床的研究 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | The Additive Effect of Risedronate, a Bisphosphonate, on the Bone Mineral Density (BMD) in Osteopenic Postmenopausal Women Treated with Long-term Hormone Replacement Therapy (HRT) and the Long-term HRT Effect on the BMD in Older Postmenopausal Women | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題 | 骨量減少 | |||||
キーワード | ||||||
主題 | ホルモン補充療法 | |||||
キーワード | ||||||
主題 | リセドロネート | |||||
キーワード | ||||||
主題 | ビスフォスフォネート | |||||
キーワード | ||||||
主題 | 骨代謝マーカー | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
雑誌書誌ID | ||||||
収録物識別子 | AA00629581 | |||||
論文名よみ | ||||||
タイトル | チョウキ ホルモン ホジュウ リョウホウ (hormone replacement therapy:HRT) シコウチュウ ノ コツリョウ ゲンショウ ヘイケイゴ ジョセイ ノ コツミツド ニ タイスル ビスフォスフォネート セイザイ ヘイヨウ コウカ ト チョウキ HRT シコウチュウ ノ コウレイ ジョセイ 二オケル コツミツド ノ ヘンカ ニ カンスル リンショウテキ ケンキュウ | |||||
著者 |
濱田, 佳伸
× 濱田, 佳伸× Hamada, Yoshinobu |
|||||
著者所属(日) | ||||||
獨協医科大学越谷病院産科婦人科 | ||||||
著者所属(英) | ||||||
en | ||||||
Department of Obstetrics and Gynecology, Dokkyo Medical University Koshigaya Hospital | ||||||
記事種別(日) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 原著 | |||||
記事種別(英) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Original | |||||
抄録(日) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 近年,強力な骨吸収抑制作用を持つビスフォスフォネート製剤が骨粗鬆症の治療に使用されている.長期間(3年以上,平均±SE:6.0±1.2年)のホルモン補充療法(hormone replacement therapy:HRT)を施行中の骨量減少患者を対象にリセドロネート2.5mg/日を投与し[Risedronate (Ris)+HRT群, n=11],投与前と投与後42ヶ月間, 6ヶ月に1回,骨密度(bone mineral density:BMD)を測定した.また,長期HRT施行中でBMDが正常の比較的高齢女性(HRT単独群,平均59.7±1.6歳, n=13),およびHRTを行っていないがBMDが正常の高齢女性(無治療群,平均57.3±1.6歳, n=20)の42ヶ月にわたるBMDの変化を比較した. Ris+HRT群のBMDは投与開始後全期間を通じて持続的に有意に増加した. HRT単独群のBMDは全期間を通じて有意な変化を認めなかったが,無治療群のBMDは,観察開始後18~42ヶ月で有意に低下した.これらより長期HRT施行中の骨量減少患者に対するリセドロネートのBMD増加効果を明らかにした.また,高齢女性における長期HRT (半量投与を含む)のBMD維持効果が判明した. | |||||
抄録(英) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Hormone replacement therapy (HRT) improves the bone mineral density (BMD) of postmenopausal patients with osteoporosis or osteopenia. However, treatment with long-term HRT for more than 3 years diminishes an increasing effect on BMD but prevents further bone loss. The present studies were designed to investigate the effects of rise-dronate (Ris), a pyridinyl bisphosphonate, on BMD in osteopenic postmenopausal women with a mean age of 50.3±2.9 years who had received long-term HRT for more than 3 years and of long-term HRT on BMD in relatively older women with normal BMD. 2.5mg daily of risedronate was administered for 42 months to 11 osteopenic postmenopausal women treated with long-term HRT, the duration of which was 6.0±1.2 years (Ris+HRT group). BMD and biochemical bone markers were determined at the initiation of observation and thereafter every 6 months for 42 months in the above-mentioned 11 osteopenic women, 13 relatively older women with a mean age of 59.2±1.6 years who had received long-term HRT for an average of 6.1±0.7 years (HRT group) and other 20 relatively older women with a mean age of 57.3±1.6 years who had never received HRT (non-HRT group), The BMD in the women of both older groups were normal when the study was initiated. Percent changes of BMD in the Ris+HRT group were significantly increased all through the 42 months. Those in the HRT group did not show any significant changes for 42 months and those in the non-HRT group were significantly decreased between 18 and 42 months after the initiation of observation. These results indicate that Ris significantly increases the BMD in those who had received long-term HRT and treatment with long-term HRT including half a dose of HRT is effective for maintaining the BMD in older postmenopausal women. | |||||
書誌情報 |
Dokkyo journal of medical sciences 巻 35, 号 1, p. 27-36, 発行日 2008-03-01 |
|||||
ISSN | ||||||
収録物識別子 | 03855023 |